Performance of risk-based criteria for targeting acute hiv screening in san francisco

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Facente, Shelley N ^a,b   Pilcher, Christopher D ^b   Hartogensis, Wendy E ^b   Klausner, Jeffrey D ^c   Philip, Susan S ^c   Louie, Brian ^c   Christopoulos, Katerina A ^b   Dowling, Teri ^c   Colfax, Grant N ^c  

^a Facente Consulting   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; VIRUS ANTIBODY; VIRUS RNA; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ANUS INTERCOURSE; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HIGH RISK BEHAVIOR; HIGH RISK PATIENT; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PATIENT IDENTIFICATION; PROCESS DEVELOPMENT; PROGNOSIS; RISK ASSESSMENT; RNA ANALYSIS; SCREENING TEST; SELF REPORT; SENSITIVITY ANALYSIS; UNITED STATES; ACUTE DISEASE; BIOLOGICAL MODEL; CD4 LYMPHOCYTE COUNT; IMMUNOLOGY; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; REPRODUCIBILITY; RISK FACTOR; VIRUS LOAD; VIRUS SHEDDING;

ACUTE DISEASE; ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; HIV; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SAN FRANCISCO; VIRAL LOAD; VIRUS SHEDDING;

EID: 79959937505     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021813     Document Type: Article

References (27)

1. Centers for Disease Control and Prevention (1989) Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR 38 (No. SU-7).
2. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, et al. (2006) Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 55 (RR-14): 1-17.
3. Pilcher CD, Tien HC, Eron JJ Jr, Vernazza PL, Leu SY, et al. (2004) Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 189 (10): 1785-92.
4. Pilcher CD, Fiscus SA, Nguyen TQ, Foust E, Wolf L, et al. (2005) Detection of acute infections during HIV testing in North Carolina. N Engl J Med 352 (18): 1873-83.
5. Patel P, Klausner JD, Bacon OM, Liska S, Taylor M, et al. (2006) Detection of acute HIV infections in high-risk patients in California. J Acquir Immune Defic Syndr 42 (1): 75-9.
6. Stekler J, Swenson PD, Wood RW, Handsfield HH, Golden MR, (2005) Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with men. AIDS 19: 1321-27.
7. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, et al. (2005) Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 191 (9): 1403-9.
8. Pilcher CD, Joaki G, Hoffman IF, Martinson FE, Mapanje C, et al. (2007) Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS 21 (13): 1723-30.
9. Brooks JT, Robbins KE, Youngpairoj AS, Rotblatt H, Kerndt PR, et al. (2006) Molecular analysis of HIV strains from a cluster of worker infections in the adult film industry, Los Angeles 2004. AIDS 20 (6): 923-8.
10. Association of Public Health Laboratories (APHL), Centers for Disease Control and Prevention (2009) HIV Testing Algorithms: A Status Report. Available: http://www.aphl.org/aphlprograms/infectious/hiv/Documents/StatusReportFINAL.pdf. Accessed 2011 June 13.
11. Pilcher CD, Fiscus SA, Nguyen TQ, Foust E, Wolf L, et al. (2005) Detection of acute infections during HIV testing in North Carolina. N Engl J Med 352 (18): 1873-83.
12. Sherlock M, Zetola NM, Klausner JD, (2007) Routine detection of acute HIV infection through RNA pooling: survey of current practice in the United States. Sex Transm Dis 34: 314-6.
13. Westreich DJ, Hudgens MG, Fiscus SA, Pilcher CD, (2008) Optimizing screening for acute human immunodeficiency virus infection with pooled nucleic acid amplification tests. J Clin Microbiol 46 (5): 1785-92 Epub 2008 Mar 19.
14. Bayer Healthcare (2004) Versant HIV-1 RNA 3.0 Assay (bDNA) [U.S. package insert] Tarrytown, NY Bayer HealthCare.
15. Abbott Molecular (2009) Abbott RealTime HIV-1 Assay [U.S. package insert] Des Plaines, IL Abbott Molecular.
16. Schneider E, Whitmore S, Glynn KM, Dominguez K, Mitsch A, et al. (2008) Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years-United States, 2008. MMWR Recomm Rep 57 (RR-10): 1-12.
17. Miller WC, Leone PA, McCoy S, Nguyen TQ, Williams DE, et al. (2009) Targeted testing for acute HIV infection in North Carolina. AIDS 23 (7): 835-43.
18. Powers KA, Miller WC, Pilcher CD, Mapanje C, Martinson FE, et al. (2007) Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm. AIDS 21 (16): 2237-42.
19. Stein CR, Kaufman JS, Ford CA, Leone PA, Feldblum PJ, et al. (2008) Screening Young Adults for Prevalent Chlamydial Infection in Community Settings. Ann Epidemiol 18 (7): 560-571.
20. Plant AJ, Rushworth RL, (1998) "Death by Proxy": Ethics and Classification in Epidemiology. Soc Sci Med 47 (9): 1147-1153.
21. Braunstein SL, van de Wijgert JH, Nash D, (2009) HIV incidence in sub-Saharan Africa: a review of available data with implications for surveillance and prevention planning. AIDS Rev 11 (3): 140-56.
22. Karita E, Price M, Hunter E, Chomba E, Allen S, et al. (2007) Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS 21 (4): 403-8.
23. McWalter TA, Welte A, (2009) A comparison of biomarker based incidence estimators. PLoS One 4 (10): e7368.
24. Miller WC, Leone PA, McCoy S, Nguyen TQ, Williams DE, et al. (2009) Targeted testing for acute HIV infection in North Carolina. AIDS 23 (7): 835-43.
25. San Francisco Department of Public Health (2010) San Francisco HIV Prevention Plan San Francisco San Francisco Department of Public Health.
26. San Francisco Department of Public Health (2009) HIV/AIDS Epidemiology Annual Report, 2009 San Francisco San Francisco Department of Public Health.
27. Abbott Laboratories (2009) ARCHITECT HIV Ag/Ab Combo Package Insert. Available: http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM216309.pdf. Accessed 2011 June 13.